Orencia and Evista drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Orencia (abatacept) and Evista (raloxifene hydrochloride). Common drug interactions include adverse drug reaction among females.

The phase IV clinical study analyzes what interactions people have when they take Orencia and Evista. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Orencia?

Orencia has active ingredients of abatacept. It is often used in rheumatoid arthritis. eHealthMe is studying from 135,415 Orencia users. Check the latest studies of Orencia.

What is Evista?

Evista has active ingredients of raloxifene hydrochloride. It is often used in osteoporosis. eHealthMe is studying from 25,891 Evista users. Check the latest studies of Evista.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 18, 2026

20 people who take Orencia and Evista together, and have interactions are studied.

What are the common drug interactions of Orencia and Evista, by gender? *:

female:

Adverse drug reaction
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Epistaxis (bleed from the nose)
Ludwig angina (a type of cellulitis that involves the floor of the mouth, under the tongue)
Palpitations (feelings or sensations that your heart is pounding or racing)
Pneumonia
Renal failure acute (rapid kidney dysfunction)
Sinusitis (inflammation of sinus)
Sluggishness (lacking alertness)
Urinary tract infection

male:

n/a

What are the common drug interactions of Orencia and Evista, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Adverse drug reaction
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Pancreatitis acute (sudden inflammation of pancreas)
Multi-organ failure (multisystem organ failure)

60+:

Pruritus (severe itching of the skin)
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Urinary tract infection
Bradycardia (abnormally slow heart action)
Ludwig angina (a type of cellulitis that involves the floor of the mouth, under the tongue)
Multi-organ failure (multisystem organ failure)
Palpitations (feelings or sensations that your heart is pounding or racing)
Pneumonia
Renal failure acute (rapid kidney dysfunction)
Sinusitis (inflammation of sinus)

What are the existing conditions these people have? *

High Blood Pressure: 2 people, 10.00%
Thyroid Diseases: 1 person, 5.00%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 5.00%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 5.00%
Atherosclerosis (disorder of the arteries): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Orencia and Evista?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously